Vertigo FX
Natural health product licensed in Canada
- Other names
- Vertigo Relief Formula
- Licence holder
- Phyto Nutrients Inc.
- NPN or DIN-HM
- 80133725
- Status
- Active licence
- Licence date
- 22 August 2024
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Actaea racemosa L.: Seuls les extraits aqueux et hydro-alcooliques de titre faible (30 %) sont admis. La portion journalière recommandée ne doit pas conduire à une ingestion de glycosides de triterpène (calculés comme 27-déoxyactéine) supérieure à 3 mg.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Ginkgo biloba Source : Ginkgo biloba - feuille Extract : Matériel brut sec Extraction ratio : 50:1 Dry plant equivalent : 1,450 mg Potency : 24 % Flavonoid glycosides | 29 mg | Not calculated |
| Ginkgo biloba Source : Ginkgo biloba - feuille Potency : 6 % Terpene lactones | Not specified | Not calculated |
| Actaea racemosa Source : Actaea racemosa - racine Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 200 mg | 50 mg | Not calculated |
| Zingiber officinale Source : Zingiber officinale - Rhizome Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 700 mg | 175 mg | Not calculated |
| Vitamine B12 Source : Méthylcobalamine | 10 microgram | 40 µg |
| Magnésium Source : Oxyde de magnésium | 10 mg | 40,000 µg |
Non-medicinal ingredients
Cellulose microcristalline, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 4 Capsule | 1 day |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps prevent nausea and vomiting associated with motion sickness, and/or seasickness. Curcuma longa is traditionally used in Ayurveda to relieve pain and inflammation. Actaea racemosa is traditionally used in Herbal Medicine to help ease nervous tension (calmative). Helps to support peripheral circulation. Used in Herbal Medicine as an adaptogen to help increase energy and resistance to stress (e.g. in case of mental and physical fatigue related to stress). Helps in energy metabolism/(and) tissue formation. Helps to maintain/support normal red blood cells. Helps with immune function/the immune system. Tribulus terrestris is used in Traditional Chinese Medicine TCM to calm the Liver and anchor the yang: for headache, vertigo, or dizziness from ascendant Liver yang.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80133725
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.